+0.03
+0.07%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 39.91 |
| Category | Health |
| Net Assets | 617.71 Mil |
| Yield | 0.44% |
| Morningstar Risk | Below Average |
| Morningstar Return | Above Average |
- Last NAV update 5/24/2013 4:00 PM ET
| NA |
|---|
| The investment seeks to provide long-term growth of capital. The fund invests at least 80% of total assets in equity securities, primarily common stock, of companies in health science and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It concentrates its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries. The fund is non-diversified. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 27.69% | 7.50% | 6.24% | 18.77% | 23.50% |
| Value ($) | 12,769.00 | 13,726.68 | 14,583.22 | 17,320.49 | 21,390.81 |
- Year to date performance as of 5/23/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | BlackRock |
| Fund Manager | Thomas Callan |
| Tenure (Years) | 8 |
| Fund Status | Open |
| Minimum Initial Purchase | 2.00 Mil |
| Minimum IRA Investment | NA |
| Front Load | 0.00 |
| Expense Ratio | 0.98% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 2.62% |
| 3 Months | 13.18% |
| 1 Year | 37.33% |
| 3 Years* | 19.96% |
| 5 Years* | 13.71% |
- * Annualized returns
- Performance as of 5/23/2013 8:00 PM ET
| SHSSX | Health | |
|---|---|---|
| 5-Yr Return | 13.71% | 12.34% |
| Sharpe Ratio | 1.24 | 1.13 |
| Net Assets | 617.71 Mil | 504.68 Mil |
| Avg Market Cap | 29.43 Bil | 18.61 Bil |
| Avg P/E | 21.21 | 18.60 |
| Portfolio Turnover | 135 | 48 |
| Symbol | Value ($) |
|---|---|
| Stocks | 98.00% |
| Cash | 1.89% |
| Fixed Income | 0.00% |
| Other | 0.12% |
| NAME | % NET ASSETS |
|---|---|
| Pfizer Inc | 5.02% |
| Roche Holding AG | 4.61% |
| Gilead Sciences Inc | 4.50% |
| Celgene Corporation | 3.86% |
| Novartis AG | 3.81% |
| Amgen Inc | 3.81% |
| Johnson & Johnson | 3.59% |
| Bristol-Myers Squibb Company | 3.33% |
| Eli Lilly and Company | 3.18% |
| Sanofi | 3.14% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
